Detalles de la búsqueda
1.
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Blood
; 137(19): 2646-2656, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512419
2.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet
; 394(10216): 2271-2281, 2019 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31868632
3.
Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial.
Br J Haematol
; 184(5): 760-768, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30520013
4.
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial.
Leukemia
; 38(5): 1099-1106, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538861
5.
Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Biol Blood Marrow Transplant
; 19(11): 1632-7, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23850653
6.
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).
Lancet Oncol
; 13(12): 1250-9, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23168367
7.
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial.
Hemasphere
; 7(7): e917, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37427145
8.
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
Hemasphere
; 7(7): e904, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37427146
9.
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Blood
; 116(18): 3418-25, 2010 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-20660290
10.
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
Lancet Haematol
; 8(4): e267-e277, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33667420
11.
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.
Leukemia
; 35(1): 143-155, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32382083
12.
Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease.
Bone Marrow Transplant
; 54(6): 877-884, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30413811
13.
Central Nervous System Prophylaxis for Aggressive B-cell Lymphoma: Who, What, and When?
Hematol Oncol Clin North Am
; 30(6): 1277-1291, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27888881
14.
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.
J Clin Oncol
; 34(26): 3150-6, 2016 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27382100
15.
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
J Clin Oncol
; 30(33): 4117-23, 2012 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23045592
16.
Reply to A. Korfel et al.
J Clin Oncol
; 34(15): 1831-2, 2016 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27001575
17.
Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.
Cancer
; 117(9): 1901-10, 2011 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21509767
Resultados
1 -
17
de 17
1
Próxima >
>>